{"raw_mentions": "There are no sentences that meet the specified criteria in the provided text snippet. The text appears to be a descriptive passage about the invention and its background, but it does not contain specific numeric values associated with bioactivity metrics (IC50, Ki, Kd, EC50) along with their respective units."}
{"raw_mentions": "Here are the extracted sentences with concrete data points:\n\nWith a Michaelis-Menten constant (Km) of 170 nanomolar (nM), PDE9A has high affinity for cGMP.\nIn addition, PDE9A is selective for cGMP (Km for cAMP=230 micromolar (\u03bcM).\nAn IC50 of 35 micromolar (\u03bcM) has been demonstrated for zaprinast (Fisher et al., J. Biol. Chem., 1998, 273 (25), 15559-15564).\nThis has, like the human form, high affinity for cGMP with a Km of 70 nanomolar (nM).\nThe IC50 for zaprinast is 29 micromolar (Soderling et al., J. Biol. Chem., 1998, 273 (19), 15553-15558).\nPDE2A (Km=10 micromolar (\u03bcM); Martins et al., J. Biol. Chem., 1982, 257, 1973-1979), \nPDE5A (Km=4 micromolar (\u03bcM); Francis et al., J. Biol. Chem., 1980, 255, 620-626), \nPDE6A (Km=17 micromolar; Gillespie and Beavo, J. Biol. Chem., 1988, 263 (17), 8133-8141 ) \nPDE11A (Km=0.52 micromolar; Fawcett et al., Proc. Nat. Acad. Sci., 2000, 97 (7), 3702-3707)."}
{"final_json": [{"molecule_name": "cGMP", "protein_target_name": "PDE9A", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Km", "value": "170", "unit": "nM"}, {"molecule_name": "cAMP", "protein_target_name": "PDE9A", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Km", "value": "230", "unit": "\u03bcM"}, {"molecule_name": "zaprinast", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "35", "unit": "\u03bcM"}, {"molecule_name": "cGMP", "protein_target_name": "human form", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Km", "value": "70", "unit": "nM"}, {"molecule_name": "zaprinast", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "29", "unit": "\u03bcM"}, {"molecule_name": "cGMP", "protein_target_name": "PDE2A", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Km", "value": "10", "unit": "\u03bcM"}, {"molecule_name": "cGMP", "protein_target_name": "PDE5A", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Km", "value": "4", "unit": "\u03bcM"}, {"molecule_name": "cGMP", "protein_target_name": "PDE6A", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Km", "value": "17", "unit": "\u03bcM"}, {"molecule_name": "cGMP", "protein_target_name": "PDE11A", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Km", "value": "0.52", "unit": "\u03bcM"}]}
{"raw_mentions": "There are no sentences that meet the specified criteria in the provided text snippet. The text appears to be a patent description and does not contain specific bioactivity metrics (IC50, Ki, Kd, EC50) with associated numeric values and units."}
{"raw_mentions": "There are no sentences that meet the specified criteria. The text does not contain any sentences with a bioactivity metric (IC50, Ki, Kd, EC50), a specific numeric value, and a unit for that value."}
{"raw_mentions": "Here are the extracted sentences with concrete data points that meet the specified criteria:\n\n\nIn the following, % inhibition (%l) data at 10 micromolar concentration (at 10 microM) and IC50 values for PDE9A2 inhibition [nanomolar (nM)] will illustrate that the compounds according to the present invention are suited to inhibit PDE9, specifically PDE9A2. \n\n\nTable 4 l% (at 10 microM): inhibition at 10 micromolar concentration. IC50 (nM): IC50 values for PDE9A2 inhibition [nanomolar (nM)] S: selectivity values [= (IC50 for PDE1 C inhibition) / (IC50 for PDE9A2 inhibition)]"}
{"final_json": [{"molecule_name": null, "protein_target_name": "PDE9A2", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": null, "unit": "nM"}]}
